Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Cathie Wood's investment manager added to its holdings in Coinbase (COIN), Bitmine (BMNR), Circle Internet Group (CRCL) and Bullish (BLSH)....
The new product was inspired by a popular episode of the 90s sitcom "Friends," which centered around a stolen Thanksgiving leftover sandwich....
New analysis reveals why America's $5 trillion AI race against China proves as consequential as the Cold War, citing economic dominance and national security at stake....
